Skip to content

Pediatric Alliance for International Neurogastrointestinal Functional Research

Pediatric Alliance for International Neurogastrointestinal Functional Research Registry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01099787
Enrollment
348
Registered
2010-04-08
Start date
2010-04-30
Completion date
2017-06-30
Last updated
2018-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Brief summary

To explore the predictive value of alarm signs (red flags) for a diagnosis of functional gastrointestinal disorders (FGID) in children. To assess the natural history of pain predominant functional gastrointestinal disorders (FGID) in newly diagnosed pediatric patients. To document the benefit of various treatment regimens currently employed in managing FGID. To assess the short- and long-term impact of various FGID regimens. To allow physicians to gain a better understanding of the epidemiology of FGID. Hypothesis: There are presenting symptoms or results from diagnostic tests that are more likely to associated with conditions different from FAP or IBS. Symptoms of children with FAP/IBS change overtime regardless of the treatments used.

Interventions

None listed

Sponsors

Nationwide Children's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Males and females ages 4 through 16 years of age (up to the day of the 17th birthday) * Presenting with chronic or intermittent abdominal pain of any severity lasting at least 2 months may participate in the Registry.

Exclusion criteria

* Subjects age 10 and above will be asked to complete the questionnaire themselves. Those unable to complete the questionnaire (with only some help) should not be enrolled. * Patients unable to participate in the program for at least 3 years should not be enrolled (i.e., anticipated move, etc.)

Countries

Netherlands, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026